Henry Schein Stock Price, News & Analysis

Henry Schein reported fourth-quarter 2022 net sales of $3.4 billion, reflecting a 1.2% increase versus Q4 2021. GAAP diluted EPS fell to $0.34 compared to $1.05 in the prior year, while non-GAAP diluted EPS rose to $1.21 from $1.07. Notably, internal sales grew 5.0% when excluding the impact of PPE and COVID-19 products. Guidance for 2023 non-GAAP EPS is set at $5.25 to $5.42, forecasting a -2% to +1% growth from 2022 non-GAAP EPS. The company also anticipates a 30% to 35% decline in PPE and COVID-19 product sales compared to 2022.

Henry Schein announced a new share repurchase program authorized by its Board of Directors, allowing the buyback of up to $400 million of common stock. This plan complements a previous $400 million repurchase program from August 2022, expected to conclude by the end of the first quarter of 2023. With approximately 131.5 million shares outstanding, the new authorization accounts for about 3.8% of total shares. The program underscores the company’s confidence in its BOLD +1 Strategic Plan and financial stability, which enables it to invest in growth while enhancing shareholder value.

Henry Schein, Inc. (NASDAQ: HSIC) recently opened the Nasdaq Stock Market to highlight its commitment to public-private partnerships aimed at enhancing health equity. Key initiatives like Give Kids A Smile and Release the Pressure were showcased, emphasizing the company's efforts in providing quality care to underserved populations. CEO Stanley M. Bergman remarked on the importance of these collaborations in identifying health care inequities. With over 22,000 team members and a global presence, Henry Schein has served one million customers, demonstrating its dedication to improving health care access and outcomes.

Over the past 21 years, the Give Kids A Smile (GKAS) program has provided free oral health education and services to more than seven million underserved children in the U.S. Launched in 2003, this year’s initiative includes nearly 1,200 events aimed at reaching an estimated 300,000 children. Approximately 30,000 dental professionals will volunteer, utilizing essential oral care products donated by national sponsors Colgate-Palmolive (NYSE: CL) and Henry Schein (NASDAQ: HSIC). Since 2007, Colgate has exclusively supported GKAS, while Henry Schein has contributed over $20 million in products, ensuring access to quality dental care for children in need.

Henry Schein, Inc. (NASDAQ: HSIC), the leading provider of health care solutions, will hold an Investor Meeting on February 27, 2023, at 9:00 a.m. Eastern time. This event will showcase the company's BOLD +1 Strategic Plan aimed at achieving sustainable growth. Key executives, including Stanley M. Bergman and Ronald N. South, will present financial guidance for 2023 and a long-term outlook. Registration is available on the Investor Relations website.

Henry Schein (Nasdaq: HSIC), a leading provider of health care solutions, will release its fourth quarter and full-year 2022 financial results on February 16, 2023. The earnings conference call will begin at 10:00 a.m. Eastern time, featuring CEO Stanley M. Bergman and CFO Ronald N. South. Investors can access the call via www.henryschein.com/IRwebcasts. Henry Schein serves over 1 million customers worldwide, offering solutions for dental and medical practitioners. With sales of $12.4 billion in 2021, it continues to grow within the health care sector.

Henry Schein (NASDAQ: HSIC) announced its subsidiary, eAssist Dental Solutions, has acquired a majority stake in Unitas PPO Solutions. This strategic acquisition aims to enhance eAssist's revenue cycle services and improve dental practice insurance and billing processes. The acquisition builds on a long-standing partnership and is expected to be neutral to 2022 diluted earnings per share, becoming accretive thereafter. Unitas generated sales of approximately $5 million in 2021 and its integration will help streamline operations and improve cash flow for dental practices.